Login / Signup
Manru Li
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 5
Top Topics
Chronic Obstructive Pulmonary Disease
Induced Apoptosis
Candida Albicans
Cell Death
Top Venues
Asia Pacific allergy
International immunology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yagiz Pat
,
Duygu Yazici
,
Paolo D'Avino
,
Manru Li
,
Sena Ardıçlı
,
Ozge Ardicli
,
Yasutaka Mitamura
,
Mübeccel Akdiş
,
Raja Dhir
,
Kari Christine Nadeau
,
Ioana Agache
,
İsmail Öğülür
,
Mübeccel Akdis
Recent advances in the epithelial barrier theory.
International immunology
36 (5) (2024)
Yagiz Pat
,
Duygu Yazici
,
Paolo D'Avino
,
Manru Li
,
Sena Ardıçlı
,
Ozge Ardicli
,
Yasutaka Mitamura
,
Mübeccel Akdiş
,
Raja Dhir
,
Kari Christine Nadeau
,
Ioana Agache
,
İsmail Öğülür
,
Mübeccel Akdis
Recent advances in the epithelial barrier theory.
International immunology
36 (5) (2024)
Umut Can Kucuksezer
,
Cevdet Özdemir
,
Duygu Yazici
,
Yagiz Pat
,
Yasutaka Mitamura
,
Manru Li
,
Na Sun
,
Paolo D'Avino
,
Xiangting Bu
,
Xueyi Zhu
,
Mübeccel Akdiş
,
Kari Christine Nadeau
,
İsmail Öğülür
,
Mübeccel Akdis
The epithelial barrier theory: Development and exacerbation of allergic and other chronic inflammatory diseases.
Asia Pacific allergy
13 (1) (2023)
Umut Can Kucuksezer
,
Cevdet Özdemir
,
Duygu Yazici
,
Yagiz Pat
,
Yasutaka Mitamura
,
Manru Li
,
Na Sun
,
Paolo D'Avino
,
Xiangting Bu
,
Xueyi Zhu
,
Mübeccel Akdiş
,
Kari Christine Nadeau
,
İsmail Öğülür
,
Mübeccel Akdis
The epithelial barrier theory: Development and exacerbation of allergic and other chronic inflammatory diseases.
Asia Pacific allergy
13 (1) (2023)
Umut Can Kucuksezer
,
Cevdet Özdemir
,
Duygu Yazici
,
Yagiz Pat
,
Yasutaka Mitamura
,
Manru Li
,
Na Sun
,
Paolo D'Avino
,
Xiangting Bu
,
Xueyi Zhu
,
Mübeccel Akdiş
,
Kari Christine Nadeau
,
İsmail Öğülür
,
Mübeccel Akdis
The epithelial barrier theory: Development and exacerbation of allergic and other chronic inflammatory diseases.
Asia Pacific allergy
13 (1) (2023)